New study aims to predict prostate cancer treatment success using blood and scans
NCT ID NCT02997709
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is collecting blood samples and imaging scans from 144 prostate cancer patients before, during, and after standard radiation therapy. Researchers want to see if changes in circulating tumor cells and MRI/PET imaging features can help predict how well the cancer responds to treatment. The goal is to better understand which patients benefit most from radiation, but this is an observational study and does not test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What could go wrong
- This is an observational study, not a treatment trial. It aims to gather information, not test a new therapy, so it won't directly change patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?